IL17A and lobular neoplasia: Despite the disappointing results, the potential of IL-17 antagonists in the treatment of lupus nephritis (LN) cannot be entirely dismissed, given the strong association between IL-17 and SLE/LN as well as encouraging findings from multiple case reports.